DK1399133T3 - Langvarig frigörelsessammensætning omfattende mælkesyre-glycolsyre copolymer og fremgangsmåde til fremstilling af disse - Google Patents

Langvarig frigörelsessammensætning omfattende mælkesyre-glycolsyre copolymer og fremgangsmåde til fremstilling af disse

Info

Publication number
DK1399133T3
DK1399133T3 DK02738837T DK02738837T DK1399133T3 DK 1399133 T3 DK1399133 T3 DK 1399133T3 DK 02738837 T DK02738837 T DK 02738837T DK 02738837 T DK02738837 T DK 02738837T DK 1399133 T3 DK1399133 T3 DK 1399133T3
Authority
DK
Denmark
Prior art keywords
preparing
release composition
prolonged release
lactic acid
acid copolymer
Prior art date
Application number
DK02738837T
Other languages
English (en)
Other versions
DK1399133T4 (da
Inventor
K Yamamoto
A Yamada
Yoshio Hata
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26617908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1399133(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK1399133T3 publication Critical patent/DK1399133T3/da
Publication of DK1399133T4 publication Critical patent/DK1399133T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02738837.0T 2001-06-29 2002-06-28 Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf DK1399133T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001199462 2001-06-29
JP2001340980 2001-11-06
PCT/JP2002/006526 WO2003002091A2 (en) 2001-06-29 2002-06-28 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same

Publications (2)

Publication Number Publication Date
DK1399133T3 true DK1399133T3 (da) 2009-08-03
DK1399133T4 DK1399133T4 (da) 2012-07-23

Family

ID=26617908

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02738837.0T DK1399133T4 (da) 2001-06-29 2002-06-28 Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf

Country Status (32)

Country Link
US (3) US20040241229A1 (da)
EP (2) EP1399133B2 (da)
JP (3) JP5491318B2 (da)
KR (3) KR20040018401A (da)
CN (1) CN1535141B (da)
AR (1) AR034640A1 (da)
AT (1) ATE429903T1 (da)
AU (1) AU2002311630B2 (da)
BR (1) BR0210572A (da)
CA (1) CA2451718C (da)
CO (1) CO5540368A2 (da)
CY (1) CY1109272T1 (da)
CZ (1) CZ306388B6 (da)
DE (1) DE60232147D1 (da)
DK (1) DK1399133T4 (da)
ES (1) ES2324156T5 (da)
HK (1) HK1061802A1 (da)
HU (1) HU230152B1 (da)
IL (1) IL159060A0 (da)
MX (1) MXPA03011440A (da)
MY (1) MY139606A (da)
NO (1) NO333531B1 (da)
NZ (1) NZ529968A (da)
PE (1) PE20030069A1 (da)
PL (1) PL212531B1 (da)
PT (1) PT1399133E (da)
RU (2) RU2297240C2 (da)
SI (1) SI1399133T2 (da)
SK (1) SK287568B6 (da)
TW (1) TWI225416B (da)
WO (1) WO2003002091A2 (da)
ZA (1) ZA200309153B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2605402T3 (es) 2002-06-25 2017-03-14 Takeda Pharmaceutical Company Limited Procedimiento para producir una composición de liberación sostenida
KR100684682B1 (ko) * 2002-09-24 2007-02-22 아사히 가세이 케미칼즈 가부시키가이샤 글리콜산 공중합체 및 그의 제조 방법
TW200529890A (en) * 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
TW200613012A (en) * 2004-07-02 2006-05-01 Takeda Pharmaceuticals Co Sustained-release composition, process for producing the same and use of the same
ATE382337T1 (de) * 2005-04-28 2008-01-15 Nipro Corp Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
CN101400363B (zh) 2006-01-18 2012-08-29 昌达生物科技公司 具有增强的稳定性的药物组合物
BRPI0720582B1 (pt) 2006-12-18 2021-08-24 Takeda Pharmaceutical Company Limited Composição de liberação prolongada, processo para a preparação da mesma, composição farmacêutica, agente profilático ou terapêutico, e, uso de uma substância fisiologicamente ativa
PT2115029E (pt) 2007-02-15 2015-10-26 Tolmar Therapeutics Inc Poli-(lactido/glicolido) de efeito de libertação imediata reduzido e métodos de produção de polímeros
KR101008462B1 (ko) * 2007-07-26 2011-01-14 조남열 치어류 이동용 어도 장치
KR100969641B1 (ko) * 2007-11-12 2010-07-14 민선영 저수지의 제방용 어도
KR100969642B1 (ko) * 2007-11-15 2010-07-12 민선영 하천의 보용 어도
TWI477266B (zh) * 2009-11-05 2015-03-21 Taiwan Biotech Co Ltd 連續製備微粒的方法、裝置及其收集單元
US8641900B2 (en) 2009-11-05 2014-02-04 Taiwan Biotech Co., Ltd Method and device for continuously preparing microspheres, and collection unit thereof
EP2697361A1 (en) * 2011-04-11 2014-02-19 Cellcura Asa Protein-free culture media products for manufacturing viral-based vaccines
US9517210B2 (en) 2012-07-12 2016-12-13 Takeda Pharmaceutical Company Limited Method for producing microcapsule powder
RU2572992C2 (ru) * 2012-08-28 2016-01-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Способ получения микрокапсул водорастворимых препаратов пестицидов
EP2985304A4 (en) 2013-04-11 2016-11-30 Mitsui Chemicals Inc PROCESS FOR PRODUCING LACTIC ACID GLYCOLIC ACID COPOLYMER AND METHOD OF MAKING SALT THEREOF
RU2537248C1 (ru) * 2013-05-24 2014-12-27 Екатерина Евгеньевна Быковская Способ получения микрокапсул гетероциклических соединений триазинового ряда
RU2537173C1 (ru) * 2013-05-24 2014-12-27 Александр Александрович Кролевец Способ получения микрокапсул гетероциклических соединений триазинового ряда
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US9956164B2 (en) 2014-04-16 2018-05-01 Veyx-Pharma Gmbh Veterinary pharmaceutical composition and use thereof
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
CN104224731A (zh) * 2014-09-11 2014-12-24 北京天晟泰丰医药科技有限公司 一种不含致敏性辅料的九肽微球的制备方法
JP5938762B1 (ja) * 2015-09-01 2016-06-22 日揮株式会社 マイクロカプセル製剤及びその製造方法
CN110856690A (zh) * 2018-08-22 2020-03-03 深圳善康医疗健康产业有限公司 一种植入剂包膜及干燥装置
WO2021234731A1 (en) * 2020-05-18 2021-11-25 Dr Reddy's Institute Of Life Sciences Sustained release compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
JPH0678425B2 (ja) 1984-07-06 1994-10-05 和光純薬工業株式会社 重合体の新規製造法
JPH0720859B2 (ja) 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
EP0190833B1 (en) 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
WO1989007451A1 (en) 1988-02-10 1989-08-24 Abbott Laboratories Reduced size lhrh analogs
US5110904A (en) 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
DE69129770T2 (de) * 1990-04-13 1998-11-19 Takeda Chemical Industries Ltd Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung
JP3200706B2 (ja) 1990-04-13 2001-08-20 武田薬品工業株式会社 生体内分解型高分子重合物
EP0535937B2 (en) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
JP3761594B2 (ja) * 1993-07-05 2006-03-29 武田薬品工業株式会社 徐放性製剤の製造法
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
JPH08259460A (ja) 1995-01-23 1996-10-08 Takeda Chem Ind Ltd 徐放性製剤の製造法
CA2192782C (en) * 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
HUP0100221A3 (en) * 1998-01-16 2002-11-28 Takeda Pharmaceutical Sustained release compositions, process for producing the same and utilization thereof
JPH11269094A (ja) 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
JP3716146B2 (ja) * 1998-12-15 2005-11-16 武田薬品工業株式会社 ポリマーの製造方法
CN1134479C (zh) * 1998-12-15 2004-01-14 武田药品工业株式会社 制备聚合物的方法
JP2002114667A (ja) 2000-10-11 2002-04-16 Ltt Institute Co Ltd 徐放性製剤用組成物、その製造法および徐放性マイクロカプセル製剤
TWI332407B (en) * 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
ES2605402T3 (es) * 2002-06-25 2017-03-14 Takeda Pharmaceutical Company Limited Procedimiento para producir una composición de liberación sostenida

Also Published As

Publication number Publication date
KR100988178B1 (ko) 2010-10-18
IL159060A0 (en) 2004-05-12
PE20030069A1 (es) 2003-03-17
EP1399133B1 (en) 2009-04-29
SI1399133T2 (sl) 2012-08-31
SK287568B6 (sk) 2011-02-04
SK15612003A3 (sk) 2004-07-07
WO2003002091A2 (en) 2003-01-09
DE60232147D1 (de) 2009-06-10
JP2012136530A (ja) 2012-07-19
PL367491A1 (en) 2005-02-21
BR0210572A (pt) 2004-08-03
AR034640A1 (es) 2004-03-03
CN1535141A (zh) 2004-10-06
EP1399133B2 (en) 2012-05-02
RU2297240C2 (ru) 2007-04-20
TWI225416B (en) 2004-12-21
HU230152B1 (hu) 2015-09-28
MXPA03011440A (es) 2004-07-01
RU2434644C2 (ru) 2011-11-27
NO20035737D0 (no) 2003-12-19
DK1399133T4 (da) 2012-07-23
JP2010280703A (ja) 2010-12-16
JP5860300B2 (ja) 2016-02-16
JP2015007120A (ja) 2015-01-15
RU2004102503A (ru) 2005-03-10
EP2108363A1 (en) 2009-10-14
CY1109272T1 (el) 2014-07-02
CA2451718C (en) 2011-03-15
ZA200309153B (en) 2005-01-26
US20120295848A1 (en) 2012-11-22
NO20035737L (no) 2004-02-20
US20080108778A1 (en) 2008-05-08
MY139606A (en) 2009-10-30
KR20090108640A (ko) 2009-10-15
KR20090096755A (ko) 2009-09-14
WO2003002091A3 (en) 2003-07-24
CZ20033492A3 (cs) 2005-01-12
HUP0400382A2 (hu) 2004-12-28
ES2324156T5 (es) 2012-07-23
US20040241229A1 (en) 2004-12-02
PL212531B1 (pl) 2012-10-31
CO5540368A2 (es) 2005-07-29
NO333531B1 (no) 2013-07-01
CZ306388B6 (cs) 2017-01-04
RU2006143104A (ru) 2008-06-20
AU2002311630B2 (en) 2007-07-19
PT1399133E (pt) 2009-06-05
EP1399133A2 (en) 2004-03-24
CN1535141B (zh) 2013-04-24
NZ529968A (en) 2005-08-26
US8258252B2 (en) 2012-09-04
CA2451718A1 (en) 2003-01-09
ATE429903T1 (de) 2009-05-15
SI1399133T1 (sl) 2009-10-31
ES2324156T3 (es) 2009-07-31
HK1061802A1 (en) 2004-10-08
JP5491318B2 (ja) 2014-05-14
HUP0400382A3 (en) 2010-01-28
KR20040018401A (ko) 2004-03-03
JP5931147B2 (ja) 2016-06-08

Similar Documents

Publication Publication Date Title
DK1399133T3 (da) Langvarig frigörelsessammensætning omfattende mælkesyre-glycolsyre copolymer og fremgangsmåde til fremstilling af disse
DK1330293T3 (da) Præparat til kontrolleret frigivelse omfattende mælkesyrepolymer og fremgangsmåde til fremstilling deraf
DK1449917T3 (da) Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia
DK2128246T3 (da) Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1148875T3 (da) Fremgangsmåder og sammensætninger til forögelse af antallet af hvide blodlegemer
DE60233058D1 (de) Silsesquioxanderivate und verfahren zu ihrer herstellung
DK2380568T3 (da) Fremgangsmåde til fremstilling og krystallisation af reduceret coenzyme Q 10
DK1553929T3 (da) Sammensætning med kontrolleret frigivelse.
NO20003530D0 (no) Vedvarende frigivelsessammensetning, metode for dens produksjon og anvendelse derav
IS7226A (is) Fjölbrigða form af rimonabant, framleiðsluaðferð og lyfjasamsetningar sem innihalda það
DE60238439D1 (de) Wasserabsorbierende polymere und verfahren zu deren herstellung
ATE298077T1 (de) Wärmetauscher und verfahren zu dessen herstellung
ATE554113T1 (de) Butencopolymere und verfahren zu ihrer herstellung
DK1334182T4 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
DE50208884D1 (de) System zur automatischen Personenüberwachung im häuslichen Umfeld
DK1383733T3 (da) Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1296685T3 (da) Præparater af quinolonantibiotika med forhalet frigivelse og fremgangsmåde til fremstilling deraf
DE60131121D1 (de) Wasserlösliches Copolymer, Verfahren zu dessen Herstellung und dessen Verwendung
DK1568280T3 (da) Fremgangsmåde til fremstilling af fermenteret mælk og fermenteret mælk
DK1484056T3 (da) Sammensætninger med langsom frigivelse og fremgangsmåde til fremstilling af disse
DE60207902T2 (de) Isocyanuratverbindung und Verfahren zu ihrer Herstellung
DK1171444T3 (da) Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse